These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18068671)

  • 1. Osteoclasts secrete non-bone derived signals that induce bone formation.
    Karsdal MA; Neutzsky-Wulff AV; Dziegiel MH; Christiansen C; Henriksen K
    Biochem Biophys Res Commun; 2008 Feb; 366(2):483-8. PubMed ID: 18068671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts.
    Henriksen K; Andreassen KV; Thudium CS; Gudmann KN; Moscatelli I; Crüger-Hansen CE; Schulz AS; Dziegiel MH; Richter J; Karsdal MA; Neutzsky-Wulff AV
    Bone; 2012 Sep; 51(3):353-61. PubMed ID: 22722081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast-derived activity in the coupling of bone formation to resorption.
    Martin TJ; Sims NA
    Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.
    Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y
    Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential requirement for osteoclasts in refined bone-like tissue reconstruction in vitro.
    Han D; Zhang Q
    Med Hypotheses; 2006; 67(1):75-8. PubMed ID: 16516403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe developmental bone phenotype in ClC-7 deficient mice.
    Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
    Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity.
    Iwasaki R; Ninomiya K; Miyamoto K; Suzuki T; Sato Y; Kawana H; Nakagawa T; Suda T; Miyamoto T
    Biochem Biophys Res Commun; 2008 Dec; 377(3):899-904. PubMed ID: 18952053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
    Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
    Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling.
    Lemaire V; Tobin FL; Greller LD; Cho CR; Suva LJ
    J Theor Biol; 2004 Aug; 229(3):293-309. PubMed ID: 15234198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoclast-osteoblast communication.
    Matsuo K; Irie N
    Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphene ceramics for orthopedic coating applications: an in vitro and in vivo study.
    Ramaswamy Y; Wu C; Dunstan CR; Hewson B; Eindorf T; Anderson GI; Zreiqat H
    Acta Biomater; 2009 Oct; 5(8):3192-204. PubMed ID: 19457458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resorbability of bone substitute biomaterials by human osteoclasts.
    Schilling AF; Linhart W; Filke S; Gebauer M; Schinke T; Rueger JM; Amling M
    Biomaterials; 2004 Aug; 25(18):3963-72. PubMed ID: 15046886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.
    Kim MH; Ryu SY; Bae MA; Choi JS; Min YK; Kim SH
    Food Chem Toxicol; 2008 Nov; 46(11):3375-82. PubMed ID: 18786594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the bone phenotype in ClC-7-deficient mice.
    Neutzsky-Wulff AV; Karsdal MA; Henriksen K
    Calcif Tissue Int; 2008 Dec; 83(6):425-37. PubMed ID: 18958510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is BMU-coupling a strain-regulated phenomenon? A finite element analysis.
    Smit TH; Burger EH
    J Bone Miner Res; 2000 Feb; 15(2):301-7. PubMed ID: 10703932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclast and its roles in calcium metabolism and bone development and remodeling.
    Li Z; Kong K; Qi W
    Biochem Biophys Res Commun; 2006 May; 343(2):345-50. PubMed ID: 16554033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.